Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P S Monraats
Interleukin 10: A New Risk Marker for the Development of Restenosis After Percutaneous Coronary Intervention
Genes and Immunity
Immunology
Genetics
Related publications
High Serum Concentration of Sulfatide Is a Risk Factor for Restenosis in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention
Journal of Postgenomics Drug & Biomarker Development
Restenosis After Percutaneous Transluminal Coronary Angioplasty in the Elderly. Risk Factor Analysis.
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Predictors of In-Stent Restenosis in Patients Undergoing Percutaneous Coronary Intervention
Demiroğlu Bilim University Florence Nightingale Journal of Medicine
The Prognostic Value of IL-8 for Cardiac Events and Restenosis in Patients With Coronary Heart Diseases After Percutaneous Coronary Intervention
Japanese Heart Journal
Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Treatment of OSA Reduces the Risk of Repeat Revascularization After Percutaneous Coronary Intervention
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Does a Well Developed Collateral Circulation Predispose to Restenosis After Percutaneous Coronary Intervention? An Intravascular Ultrasound Study
Heart
Cardiovascular Medicine
Cardiology
Definition of Restenosis After Percutaneous Transluminal Coronary Angioplasty: A Quickly Evolving Concept
Journal of Interventional Cardiology
Nuclear Medicine
Radiology
Cardiovascular Medicine
Imaging
Cardiology
Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment
Cardiology Research
Cardiovascular Medicine
Cardiology
